CJC-1295 (without DAC / Mod GRF 1-29) vs Semax

Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.

CJC-1295 (without DAC / Mod GRF 1-29)Semax
CategoryPeptidesPeptides
Standard DoseResearch indicates 100-300 mcg administered 1-3 times daily via subcutaneous injection.Research indicates 200-600 mcg daily via intranasal administration (0.1% solution, 2-3 drops per nostril).
TimingBest administered at bedtime (primary), upon waking, and/or post-workout. Always on empty stomach — wait 2+ hours after last meal. Avoid carbohydrates 30+ minutes after injection.Morning and early afternoon dosing (avoid evening — may cause stimulation/insomnia). Intranasal preferred for rapid CNS delivery.
Cycle Duration12-24 week cycles with 4-8 week breaks.10-14 day cycles with equal rest periods. Some protocols use 3-5 day on / 2 day off patterns.
Evidence Levelmoderate_humanmoderate_human

Mechanism

Mod GRF 1-29 (Modified Growth Hormone Releasing Factor, amino acids 1-29) is a truncated and modified GHRH analog that binds to GHRH receptors on anterior pituitary somatotrophs, activating cAMP via Gs protein/adenylate cyclase and mitogen-activated protein kinase pathways. Without the DAC moiety, it has a short half-life of approximately 30 minutes, producing acute GH pulses that more closely mimic natural pulsatile GH secretion. It also stimulates pituitary gene transcription of GH mRNA, preserving endogenous pituitary reserve.

Standard Dosing

Research indicates 100-300 mcg administered 1-3 times daily via subcutaneous injection.

Timing

Best administered at bedtime (primary), upon waking, and/or post-workout. Always on empty stomach — wait 2+ hours after last meal. Avoid carbohydrates 30+ minutes after injection.

Cycle Duration

12-24 week cycles with 4-8 week breaks.

Side Effects

  • Flushing post-injection
  • Head rush
  • Hunger increase
  • Water retention (mild)
  • Tingling in extremities

Contraindications

  • Active cancer
  • Diabetic retinopathy
  • Pregnancy and breastfeeding
  • Intracranial hypertension

Best Stacking Partners

IpamorelinGHRP-2GHRP-6Hexarelin
B

Semax

Peptides

Mechanism

Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic heptapeptide analog of the ACTH(4-10) fragment that rapidly upregulates brain-derived neurotrophic factor (BDNF) and its signaling receptor TrkB in the hippocampus (1.4-fold BDNF protein increase, 3-fold exon III BDNF mRNA increase). It activates dopaminergic and serotonergic brain systems, enhances neurotrophin gene expression (BDNF, NGF), and modulates intracellular calcium dynamics in brain neurons. Semax lacks ACTH's corticotropic activity, acting purely as a nootropic/neuroprotective agent.

Standard Dosing

Research indicates 200-600 mcg daily via intranasal administration (0.1% solution, 2-3 drops per nostril).

Timing

Morning and early afternoon dosing (avoid evening — may cause stimulation/insomnia). Intranasal preferred for rapid CNS delivery.

Cycle Duration

10-14 day cycles with equal rest periods. Some protocols use 3-5 day on / 2 day off patterns.

Side Effects

  • Nasal irritation (intranasal route)
  • Mild headache
  • Stimulation/insomnia if dosed late
  • Irritability at high doses
  • Hair loss (anecdotal at high doses)

Contraindications

  • Seizure disorders
  • Acute psychosis or mania
  • Pregnancy and breastfeeding
  • Severe hypertension

Best Stacking Partners

SelankP21Noopept

Not sure which is right for you?

Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.

Get Your Free Protocol →or take the assessment →